Form 8-K - Current report:
SEC Accession No. 0001683168-21-000711
Filing Date
2021-02-25
Accepted
2021-02-25 09:00:56
Documents
28
Period of Report
2021-02-25
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cns_8k.htm 8-K 18956
2 CNS PHARMACEUTICALS, INC. INVESTOR PRESENTATION - FEBRUARY 2021 cns_ex9901.htm EX-99.1 45160
3 GRAPHIC image_001.jpg GRAPHIC 62825
4 GRAPHIC image_002.jpg GRAPHIC 78625
5 GRAPHIC image_003.jpg GRAPHIC 84419
6 GRAPHIC image_004.jpg GRAPHIC 123550
7 GRAPHIC image_005.jpg GRAPHIC 66819
8 GRAPHIC image_006.jpg GRAPHIC 102394
9 GRAPHIC image_007.jpg GRAPHIC 95658
10 GRAPHIC image_008.jpg GRAPHIC 125098
11 GRAPHIC image_009.jpg GRAPHIC 105279
12 GRAPHIC image_010.jpg GRAPHIC 94717
13 GRAPHIC image_011.jpg GRAPHIC 96914
14 GRAPHIC image_012.jpg GRAPHIC 111863
15 GRAPHIC image_013.jpg GRAPHIC 105557
16 GRAPHIC image_014.jpg GRAPHIC 105969
17 GRAPHIC image_015.jpg GRAPHIC 120520
18 GRAPHIC image_016.jpg GRAPHIC 97329
19 GRAPHIC image_017.jpg GRAPHIC 112414
20 GRAPHIC image_018.jpg GRAPHIC 121260
21 GRAPHIC image_019.jpg GRAPHIC 88798
22 GRAPHIC image_020.jpg GRAPHIC 132822
23 GRAPHIC image_021.jpg GRAPHIC 74309
24 GRAPHIC image_022.jpg GRAPHIC 83499
25 GRAPHIC image_023.jpg GRAPHIC 132548
26 GRAPHIC image_024.jpg GRAPHIC 103494
27 GRAPHIC image_025.jpg GRAPHIC 102808
28 GRAPHIC image_026.jpg GRAPHIC 59851
  Complete submission text file 0001683168-21-000711.txt   3635029
Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185 X701
CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)

IRS No.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39126 | Film No.: 21676687
SIC: 2834 Pharmaceutical Preparations